# Role of Prophylactic Antiemetics in Women Receiving Intrathecal Morphine and Lipophilic Opioids Added to Bupivacaine for Cesarean Section

> **NCT06704139** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 100 (estimated)

## Conditions studied

- Cesarean Section

## Interventions

- **DRUG:** Morphine - .25 mg
- **DRUG:** fentanyl + morphine
- **DRUG:** Ondansetron + Dexamethasone

## Key facts

- **NCT ID:** NCT06704139
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2026-12-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06704139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06704139, "Role of Prophylactic Antiemetics in Women Receiving Intrathecal Morphine and Lipophilic Opioids Added to Bupivacaine for Cesarean Section". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06704139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*